The reverse split is a compliance-driven event with no operational catalyst. Post-split price will be ~25x pre-split, but the stock remains at risk of further decline if fundamentals do not improve. Monitor for any subsequent capital raises or pipeline updates.
Price Chart
Executive Summary
Propanc Biopharma announced a 1-for-25 reverse stock split approved by the board on March 16, 2026, effective May 18, 2026, to regain Nasdaq compliance with the $1.00 minimum bid price. The split reduces outstanding shares from ~57M to ~2.3M. This is a mechanical compliance action with no change to the company's fundamental business or pipeline status.
Key Facts
- 1-for-25 reverse stock split approved by board on March 16, 2026, effective May 18, 2026.
- Outstanding shares reduced from ~56,959,280 to ~2,278,372 on a pro forma basis.
- Fractional shares rounded up to the nearest whole share per shareholder.
- Ticker remains PPCB with a new CUSIP number 74346N800.
- Purpose is to restore compliance with Nasdaq's $1.00 minimum bid price requirement.
- No change to par value ($0.001 per share).
Financial Impact
Reverse stock split is a mechanical adjustment; no change to market cap or enterprise value. Share count reduction from ~57M to ~2.3M.
Risk Factors
- Reverse splits often precede dilutive offerings; watch for a capital raise announcement.
- Nasdaq compliance regained temporarily, but sustained price above $1.00 is not guaranteed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3294583 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $0.2800 | awaiting T+5 | — | — |
Oct 5, 2026 21d ago | S-1 | $0.4913 $0.4125 | ▲ +16.04% | ▲ +15.90% | — |
Sep 29, 2026 27d ago | Press Release | $0.5123 $0.4913 | ▼ −4.10% | ▼ −6.05% | — |
Aug 18, 2026 9w ago | Press Release | $1.16 $1.13 | ▼ −2.59% | ▼ −2.39% | — |
Jul 14, 2026 14w ago | 8-K | $1.63 $1.44 | ▼ −11.66% | ▼ −10.68% | — |
May 19, 2026 22w ago | Press Release | $2.01 $1.62 | ▼ −19.20% | ▼ −21.45% | — |
May 15, 2026 23w ago | Press Release | $1.70 $1.76 | ▲ +3.53% | ▲ +2.57% | — |
May 13, 2026 23w ago | Press Release | $1.83 $1.73 | ▼ −5.34% | ▼ −4.62% | — |
Apr 21, 2026 26w ago | EFFECT | $2.83 $2.65 | ▼ −6.28% | ▼ −7.36% | — |
Mar 24, 2026 30w ago | Press Release | $2.77 $2.65 | ▼ −4.33% | ▼ −3.91% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers